SONOGEN
The vision behind SONOGEN, INTLAB's pharmacogenetic expert system, is to find the customized therapy for each patient in advance.
People react very differently to one and the same drug. What helps one person has no effect on another or has serious side effects. How someone reacts depends on their genes and can be found out with so-called pharmacogenetic tests.
Customized medication instead of trial and error
Avoidance of adverse drug reactions
Faster to treatment success
Lower costs through
efficient therapy
The vision behind SONOGEN, INTLAB's pharmacogenetic expert system, is to find the customized therapy for each patient in advance.
At INTLAB, we want to make the benefits of pharmacogenetics available to as many people as possible. Our vision: safe and efficient personalized medicine for all.
[1] Swen JJ, van der Wouden CH, Manson LE, Abdullah-Koolmees H, Blagec K, Blagus T, Böhringer S, Cambon-Thomsen A, Cecchin E, Cheung KC, Deneer VH, Dupui M, Ingelman-Sundberg M, Jonsson S, Joefield-Roka C, Just KS, Karlsson MO, Konta L, Koopmann R, Kriek M, Lehr T, Mitropoulou C, Rial-Sebbag E, Rollinson V, Roncato R, Samwald M, Schaeffeler E, Skokou M, Schwab M, Steinberger D, Stingl JC, Tremmel R, Turner RM, van Rhenen MH, Dávila Fajardo CL, Dolžan V, Patrinos GP, Pirmohamed M, Sunder-Plassmann G, Toffoli G, Guchelaar HJ; Ubiquitous Pharmacogenomics Consortium. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study. Lancet. 2023 Feb 4;401(10374):347-356. doi: 10.1016/S0140-6736(22)01841-4. erratum in: Lancet. 2023 Aug 26;402(10403):692. PMID: 36739136.
